Research Topics
| Jody L KujovichSummaryAffiliation: Oregon Health and Science University Country: USA Publications
| Collaborators |
Detail Information
Publications
Hormones and pregnancy: thromboembolic risks for womenJody L Kujovich
Division of Hematology Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA
Br J Haematol 126:443-54. 2004..This review focuses on recent data estimating the thrombotic risk of hormonal therapies and pregnancy in women with and without other thrombotic risk factors...
Thrombophilia and pregnancy complicationsJody L Kujovich
Division of Hematology Medical Oncology, Oregon Health and Science University, 3181 SE Sam Jackson Park Road, Portland, OR 97239, USA
Am J Obstet Gynecol 191:412-24. 2004..Study design Electronic databases and manual bibliography searches were used to identify studies evaluating the association between thrombophilia and pregnancy loss, preeclampsia, fetal growth retardation, and placental abruption...
von Willebrand disease and pregnancyJ L Kujovich
Division of Hematology/Medical Oncology, Mail Code: L-586, Oregon Health and Science University, Portland, OR 97239, USA
J Thromb Haemost 3:246-53. 2005
von Willebrand's disease and menorrhagia: prevalence, diagnosis, and managementJody L Kujovich
Division of Hematology Medical Oncology, Oregon Health and Science University, Portland, Oregon 97239 3098, USA
Am J Hematol 79:220-8. 2005..Until these studies are completed, treatment should be individualized based on von Willebrand's disease subtype, patient age, contraceptive needs, and personal preference...
Hemostatic defects in end stage liver diseaseJody L Kujovich
Division of Hematology and Medical Oncology, Mail Code L 586, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR 97239 3098, USA
Crit Care Clin 21:563-87. 2005..Fresh frozen plasma, cryoprecipitate, and platelet transfusion remain the mainstays of therapy until larger trials confirm the safety and efficacy of recombinant factor VIIa in this population...
Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disordersRichard D Press
Department of Pathology and Medical Genetics, Oregon Health and Science University, Portland 97201, USA
Arch Pathol Lab Med 126:1304-18. 2002..As FVL is currently the most common recognized familial thrombophilia, it is hoped that these recommendations will assist laboratorians and clinicians caring for patients (and families) with this common mutation...
Thrombophilia and thrombotic problems in renal transplant patientsJody L Kujovich
Department of Medicine, Oregon Health and Science University, Portland, OR, USA
Transplantation 77:959-64. 2004
